IP Library Granted Patent US 8,535,878
Granted Patent B2
US 8,535,878 · App. 11/743,517 · Granted Sep 17, 2013

Methods, compositions, and kits for detecting protein aggregates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,535,878
App. No.
11/743,517
Granted
Sep 17, 2013
Kind
B2
Abstract

The present teachings provide methods, compositions, and kits for detecting the presence of protein aggregates. In some embodiments, the protein aggregate is treated with a labeled precursor, and the labeled precursor is incorporated into the protein aggregate to form a labeled protein aggregate. The labeled protein aggregate is then measured, thus detecting the presence of the protein aggregate. In some embodiments, the labeled protein aggregate is detected by interaction of labeled precursors, for example by a proximity ligation assay.

Claims (9)

1. A method of detecting a protein aggregate in a sample of interest comprising:

providing a first soluble precursor molecule and a second soluble precursor molecule, wherein the first precursor molecule is attached to a first oligonucleotide, and wherein the second precursor molecule is attached to a second oligonucleotide, wherein the first soluble precursor molecule and the second soluble precursor molecule are capable of aggregating;

contacting a sample suspected of containing the protein aggregate with the first soluble precursor molecule and the second soluble precursor molecule;

aggregating the first soluble precursor molecule, and the second soluble precursor molecules and the protein aggregate, if present in the sample, together to form an oligonucleotide-labeled protein aggregate, wherein the first and second precursor molecules are incorporated into the labeled protein aggregate;

interacting the first oligonucleotide of the first precursor molecule with the second oligonucleotide of the second precursor molecule, to form an interaction composition; and,

detecting the interaction composition to detect the presence of the protein aggregate in the sample of interest; wherein the interacting comprises hybridizing the first oligonucleotide and the second oligonucleotide to a splint oligonucleotide and ligating the first oligonucleotide to the second oligonucleotide to form a ligation product.

2. The method according to claim 1 wherein the first precursor molecule and the second precursor molecule are Sup35.

3. The method according to claim 1 wherein the detecting comprises amplifying the ligation product in a PCR.

4. The method according to claim 3 wherein the PCR is a real-time PCR.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY NAME PREVIOUSLY RECORDED AT REEL: 030182 FRAME: 0677. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 038006/0600 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2007
From: RUFF, DAVID W.; SHANNON, MARK E.; LIVAK, KENNETH J.; GUEGLER, KARL J.; HENNESSY, KEVIN M.
To: APPLERA CORPORATION
Reel/Frame 019778/0346 →